Cargando…
Ethyl 2-[2,3,4-Trimethoxy-6-(1-Octanoyl)Phenyl] Acetate (TMPA) Ameliorates Lipid Accumulation by Disturbing the Combination of LKB1 with Nur77 and Activating the AMPK Pathway in HepG2 Cells and Mice Primary Hepatocytes
BACKGROUND: The AMP-activated protein kinase alpha (AMPKα) pathway has widely been considered a key factor in energy metabolism. Ethyl 2-[2,3,4-trimethoxy-6-(1-octanoyl)phenyl] acetate (TMPA) is a novel AMPK agonist, which influences the stability of Nuclear Receptor Subfamily 4, Group A, Member 1 (...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495146/ https://www.ncbi.nlm.nih.gov/pubmed/34629883 http://dx.doi.org/10.2147/DMSO.S321246 |
_version_ | 1784579475115081728 |
---|---|
author | Wang, Xiaoyu Li, Guangbing Guo, Changfa Zhang, Jiayao Kong, Junjie He, Jingyi Li, Feiyu Liu, Yong Yang, Yang Lu, Ziwen Liu, Jun |
author_facet | Wang, Xiaoyu Li, Guangbing Guo, Changfa Zhang, Jiayao Kong, Junjie He, Jingyi Li, Feiyu Liu, Yong Yang, Yang Lu, Ziwen Liu, Jun |
author_sort | Wang, Xiaoyu |
collection | PubMed |
description | BACKGROUND: The AMP-activated protein kinase alpha (AMPKα) pathway has widely been considered a key factor in energy metabolism. Ethyl 2-[2,3,4-trimethoxy-6-(1-octanoyl)phenyl] acetate (TMPA) is a novel AMPK agonist, which influences the stability of Nuclear Receptor Subfamily 4, Group A, Member 1 (Nur77)-serine-threonine kinase 11 (LKB1) in the nucleus. A recent study has determined that TMPA can ameliorate the reduction of insulin resistance in type II db/db mice. However, the role of TMPA in hepatocyte lipid metabolism has not been elucidated. OBJECTIVE: To investigate whether TMPA could ameliorate liver lipid accumulation under the stimulation of free fatty acids (FFAs) in vitro. METHODS: We evaluated differences of Nur77 and AMPK pathway in mice fed a high-fat diet and those fed a normal diet. In vitro, TMPA was added to HepG2 cells and primary hepatocytes before FFAs stimulation. Oil red O staining, Nile red staining were used to evaluate lipid deposition. Western blot and immunofluorescence were used to quantify related proteins. RESULTS: Nur77, AMPKα, LKB1, 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), acetyl-CoA carboxylase phosphorylation (p-ACC), and carnitine palmitoyltransferase 1 (CPT1A) showed significant differences in vivo. Under the intervention of TMPA, HepG2 cells and primary hepatocytes showed considerable amelioration of lipid deposition and improved the expression of phosphorylated (p)-AMPKα (p-AMPKα), p-LKB1, p-ACC, and CPT1A. Furthermore, Western blotting and immunofluorescence studies indicated that LKB1 dramatically increased expression in the cytoplasm but decreased in the nucleus. Further, AMPKα phosphorylation (p-AMPKα) also showed a higher expression in cytoplasm instead of the nucleus. CONCLUSION: TMPA ameliorated lipid accumulation by influencing the stability of Nur77-LKB1 in vitro. |
format | Online Article Text |
id | pubmed-8495146 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-84951462021-10-07 Ethyl 2-[2,3,4-Trimethoxy-6-(1-Octanoyl)Phenyl] Acetate (TMPA) Ameliorates Lipid Accumulation by Disturbing the Combination of LKB1 with Nur77 and Activating the AMPK Pathway in HepG2 Cells and Mice Primary Hepatocytes Wang, Xiaoyu Li, Guangbing Guo, Changfa Zhang, Jiayao Kong, Junjie He, Jingyi Li, Feiyu Liu, Yong Yang, Yang Lu, Ziwen Liu, Jun Diabetes Metab Syndr Obes Original Research BACKGROUND: The AMP-activated protein kinase alpha (AMPKα) pathway has widely been considered a key factor in energy metabolism. Ethyl 2-[2,3,4-trimethoxy-6-(1-octanoyl)phenyl] acetate (TMPA) is a novel AMPK agonist, which influences the stability of Nuclear Receptor Subfamily 4, Group A, Member 1 (Nur77)-serine-threonine kinase 11 (LKB1) in the nucleus. A recent study has determined that TMPA can ameliorate the reduction of insulin resistance in type II db/db mice. However, the role of TMPA in hepatocyte lipid metabolism has not been elucidated. OBJECTIVE: To investigate whether TMPA could ameliorate liver lipid accumulation under the stimulation of free fatty acids (FFAs) in vitro. METHODS: We evaluated differences of Nur77 and AMPK pathway in mice fed a high-fat diet and those fed a normal diet. In vitro, TMPA was added to HepG2 cells and primary hepatocytes before FFAs stimulation. Oil red O staining, Nile red staining were used to evaluate lipid deposition. Western blot and immunofluorescence were used to quantify related proteins. RESULTS: Nur77, AMPKα, LKB1, 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), acetyl-CoA carboxylase phosphorylation (p-ACC), and carnitine palmitoyltransferase 1 (CPT1A) showed significant differences in vivo. Under the intervention of TMPA, HepG2 cells and primary hepatocytes showed considerable amelioration of lipid deposition and improved the expression of phosphorylated (p)-AMPKα (p-AMPKα), p-LKB1, p-ACC, and CPT1A. Furthermore, Western blotting and immunofluorescence studies indicated that LKB1 dramatically increased expression in the cytoplasm but decreased in the nucleus. Further, AMPKα phosphorylation (p-AMPKα) also showed a higher expression in cytoplasm instead of the nucleus. CONCLUSION: TMPA ameliorated lipid accumulation by influencing the stability of Nur77-LKB1 in vitro. Dove 2021-10-02 /pmc/articles/PMC8495146/ /pubmed/34629883 http://dx.doi.org/10.2147/DMSO.S321246 Text en © 2021 Wang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Wang, Xiaoyu Li, Guangbing Guo, Changfa Zhang, Jiayao Kong, Junjie He, Jingyi Li, Feiyu Liu, Yong Yang, Yang Lu, Ziwen Liu, Jun Ethyl 2-[2,3,4-Trimethoxy-6-(1-Octanoyl)Phenyl] Acetate (TMPA) Ameliorates Lipid Accumulation by Disturbing the Combination of LKB1 with Nur77 and Activating the AMPK Pathway in HepG2 Cells and Mice Primary Hepatocytes |
title | Ethyl 2-[2,3,4-Trimethoxy-6-(1-Octanoyl)Phenyl] Acetate (TMPA) Ameliorates Lipid Accumulation by Disturbing the Combination of LKB1 with Nur77 and Activating the AMPK Pathway in HepG2 Cells and Mice Primary Hepatocytes
|
title_full | Ethyl 2-[2,3,4-Trimethoxy-6-(1-Octanoyl)Phenyl] Acetate (TMPA) Ameliorates Lipid Accumulation by Disturbing the Combination of LKB1 with Nur77 and Activating the AMPK Pathway in HepG2 Cells and Mice Primary Hepatocytes
|
title_fullStr | Ethyl 2-[2,3,4-Trimethoxy-6-(1-Octanoyl)Phenyl] Acetate (TMPA) Ameliorates Lipid Accumulation by Disturbing the Combination of LKB1 with Nur77 and Activating the AMPK Pathway in HepG2 Cells and Mice Primary Hepatocytes
|
title_full_unstemmed | Ethyl 2-[2,3,4-Trimethoxy-6-(1-Octanoyl)Phenyl] Acetate (TMPA) Ameliorates Lipid Accumulation by Disturbing the Combination of LKB1 with Nur77 and Activating the AMPK Pathway in HepG2 Cells and Mice Primary Hepatocytes
|
title_short | Ethyl 2-[2,3,4-Trimethoxy-6-(1-Octanoyl)Phenyl] Acetate (TMPA) Ameliorates Lipid Accumulation by Disturbing the Combination of LKB1 with Nur77 and Activating the AMPK Pathway in HepG2 Cells and Mice Primary Hepatocytes
|
title_sort | ethyl 2-[2,3,4-trimethoxy-6-(1-octanoyl)phenyl] acetate (tmpa) ameliorates lipid accumulation by disturbing the combination of lkb1 with nur77 and activating the ampk pathway in hepg2 cells and mice primary hepatocytes |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495146/ https://www.ncbi.nlm.nih.gov/pubmed/34629883 http://dx.doi.org/10.2147/DMSO.S321246 |
work_keys_str_mv | AT wangxiaoyu ethyl2234trimethoxy61octanoylphenylacetatetmpaameliorateslipidaccumulationbydisturbingthecombinationoflkb1withnur77andactivatingtheampkpathwayinhepg2cellsandmiceprimaryhepatocytes AT liguangbing ethyl2234trimethoxy61octanoylphenylacetatetmpaameliorateslipidaccumulationbydisturbingthecombinationoflkb1withnur77andactivatingtheampkpathwayinhepg2cellsandmiceprimaryhepatocytes AT guochangfa ethyl2234trimethoxy61octanoylphenylacetatetmpaameliorateslipidaccumulationbydisturbingthecombinationoflkb1withnur77andactivatingtheampkpathwayinhepg2cellsandmiceprimaryhepatocytes AT zhangjiayao ethyl2234trimethoxy61octanoylphenylacetatetmpaameliorateslipidaccumulationbydisturbingthecombinationoflkb1withnur77andactivatingtheampkpathwayinhepg2cellsandmiceprimaryhepatocytes AT kongjunjie ethyl2234trimethoxy61octanoylphenylacetatetmpaameliorateslipidaccumulationbydisturbingthecombinationoflkb1withnur77andactivatingtheampkpathwayinhepg2cellsandmiceprimaryhepatocytes AT hejingyi ethyl2234trimethoxy61octanoylphenylacetatetmpaameliorateslipidaccumulationbydisturbingthecombinationoflkb1withnur77andactivatingtheampkpathwayinhepg2cellsandmiceprimaryhepatocytes AT lifeiyu ethyl2234trimethoxy61octanoylphenylacetatetmpaameliorateslipidaccumulationbydisturbingthecombinationoflkb1withnur77andactivatingtheampkpathwayinhepg2cellsandmiceprimaryhepatocytes AT liuyong ethyl2234trimethoxy61octanoylphenylacetatetmpaameliorateslipidaccumulationbydisturbingthecombinationoflkb1withnur77andactivatingtheampkpathwayinhepg2cellsandmiceprimaryhepatocytes AT yangyang ethyl2234trimethoxy61octanoylphenylacetatetmpaameliorateslipidaccumulationbydisturbingthecombinationoflkb1withnur77andactivatingtheampkpathwayinhepg2cellsandmiceprimaryhepatocytes AT luziwen ethyl2234trimethoxy61octanoylphenylacetatetmpaameliorateslipidaccumulationbydisturbingthecombinationoflkb1withnur77andactivatingtheampkpathwayinhepg2cellsandmiceprimaryhepatocytes AT liujun ethyl2234trimethoxy61octanoylphenylacetatetmpaameliorateslipidaccumulationbydisturbingthecombinationoflkb1withnur77andactivatingtheampkpathwayinhepg2cellsandmiceprimaryhepatocytes |